建议在烧伤休克期不常规预防性全身使用抗菌药物

罗高兴; 李海胜; 袁志强; 彭毅志

doi:10.3760/cma.j.cn501225-20240809-00300

建议在烧伤休克期不常规预防性全身使用抗菌药物

doi: 10.3760/cma.j.cn501225-20240809-00300

陆军军医大学（第三军医大学）第一附属医院全军烧伤研究所,创伤与化学中毒全国重点实验室,重庆市创面修复与组织再生重点实验室,重庆　　400038

基金项目:

国家自然科学基金面上项目 82372515, 82072171

详细信息

通讯作者:
罗高兴,Email：logxw@tmmu.edu.cn

计量
- 文章访问数: 121
- HTML全文浏览量: 14
- PDF下载量: 24
- 被引次数: 0
出版历程
- 收稿日期: 2024-08-09

No administering prophylactic systemic antibiotics routinely during the shock phase after burn injury

Institute of Burn Research, State Key Laboratory of Trauma and Chemical Poisoning, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing Key Laboratory for Wound Repair and Tissue Regeneration, Chongqing 400038, China

Funds:

General Program of National Natural Science Foundation of China 82372515, 82072171

More Information

Corresponding author: Luo Gaoxing, Email: logxw@tmmu.edu.cn

摘要

摘要: 感染是烧伤最常见的并发症,但烧伤后通常不会迅速引起全身性感染。国内传统上往往在烧伤休克期即常规预防性全身使用抗菌药物,以防治烧伤感染的发生发展,但临床证据及国际烧伤感染防治专家共识与指南均强烈反对烧伤后立即常规预防性全身使用抗菌药物。笔者单位停止在严重烧伤休克期常规预防性全身使用抗菌药物后,并未观察到感染及相关并发症发生率的明显增加。故笔者团队建议,除一些特殊患者外,在烧伤休克期不常规预防性全身使用抗菌药物。
- 烧伤 /
- 感染 /
- 脓毒症 /
- 预防性全身使用抗菌药物
Abstract: Infection is the most common complication following burn injury, while it is rare to induce immediately systemic infection after burn injury. Domestically, the burn patients especially the major burn patients are conventionally administered systemic antibiotics prophylactically during the shock phase after burn injury. However, the clinical evidences and all the international expert consensuses and guidelines on burn infections object strongly and clearly administration of systemic antibiotics prophylactically. The incidences of systemic infection and sepsis did not increase significantly after prohibiting prophylactical administration of systemic antibiotics routinely during the shock phase after burn injury based on the authors unit's clinical data of more than 100 major burn patients. Herein, we propose that the burn patients should not be routinely administered systemic antibiotics prophylactically during the burn shock phase.
- Burns /
- Infection /
- Sepsis /
- Systemic administration of antibiotics prophylactically
所有作者均声明不存在利益冲突

HTML全文

参考文献(25)

[1]	LiH, ZhouJ, PengY, et al. The progress of Chinese burn medicine from the Third Military Medical University-in memory of its pioneer, Professor Li Ao[J/OL]. Burns Trauma, 2017,5:16[2024-08-09]. https://pubmed.ncbi.nlm.nih.gov/28573147/. DOI: 10.1186/s41038-017-0082-z.
[2]	JeschkeMG, van BaarME, ChoudhryMA, et al. Burn injury[J]. Nat Rev Dis Primers, 2020,6(1):11. DOI: 10.1038/s41572-020-0145-5.
[3]	KhalafF, RicciutiZ, BarayanD, et al. Post-burn endocrine-immune dynamics and ageing considerations[J]. Nat Rev Endocrinol, 2024,20(10):567-568. DOI: 10.1038/s41574-024-01018-3.
[4]	OsukaA, ShigenoA, MatsuuraH, et al. Systemic immune response of burns from the acute to chronic phase[J]. Acute Med Surg, 2024,11(1):e976. DOI: 10.1002/ams2.976.
[5]	LadhaniHA, YowlerCJ, ClaridgeJA. Burn wound colonization, infection, and sepsis[J]. Surg Infect (Larchmt), 2021,22(1):44-48. DOI: 10.1089/sur.2020.346.
[6]	GuF, HeW, ZhuD, et al. A 10-year retrospective study of methicillin-resistant Staphylococcus aureus from burn wound infection in southeast China from 2013 to 2022[J]. Front Microbiol, 2023,14:1301744. DOI: 10.3389/fmicb.2023.1301744.
[7]	WangY, LiQ, ShuQ, et al. Clinical epidemiology and a novel predicting nomogram of central line associated bloodstream infection in burn patients[J]. Epidemiol Infect, 2023,151:e90. DOI: 10.1017/S0950268823000766.
[8]	JeonK, HanSB, KymD, et al. Central venous catheter tip colonization and associated bloodstream infection in patients with severe burns under routine catheter changing[J]. Am J Infect Control, 2024,52(7):813-818. DOI: 10.1016/j.ajic.2024.02.003.
[9]	MaitzJ, MerlinoJ, RizzoS, et al. Burn wound infections microbiome and novel approaches using therapeutic microorganisms in burn wound infection control[J]. Adv Drug Deliv Rev, 2023,196:114769. DOI: 10.1016/j.addr.2023.114769.
[10]	DeyPK, GalibA, SardarA, et al. Nosocomial infection among burn patients admitted to a tertiary care hospital of Bangladesh: a cross-sectional study[J]. Ann Burns Fire Disasters, 2023,36(3):202-208.
[11]	PalmieriTL. Infection prevention: unique aspects of burn units[J]. Surg Infect (Larchmt), 2019,20(2):111-114. DOI: 10.1089/sur.2018.301.
[12]	罗高兴, 詹日兴, 袁志强, 等. 浅谈烧伤感染的分类与诊断命名[J].中华烧伤与创面修复杂志,2023,39(4):301-304. DOI: 10.3760/cma.j.cn501225-20221206-00528.
[13]	DellingerRP, CarletJM, MasurH, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004,32(3):858-873. DOI: 10.1097/01.ccm.0000117317.18092.e4.
[14]	EvansL, RhodesA, AlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021,49(11):e1063-e1143. DOI: 10.1097/CCM.0000000000005337.
[15]	BoneRC, BalkRA, CerraFB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest,1992, 101(6):1644-1655. DOI: 10.1378/chest.101.6.1644.
[16]	SingerM, DeutschmanCS, SeymourCW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016,315(8):801-810. DOI: 10.1001/jama.2016.0287.
[17]	中华医学会烧伤外科学分会.中国烧伤年度报告2010-2016[M].2017.
[18]	TanJ, LiN, GongY, et al. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis[J]. Burns, 2021,47(8):1802-1809. DOI: 10.1016/j.burns.2021.02.024.
[19]	ZhangYJ, GuoZH, MingZG, et al. Meta-analysis of the diagnostic value of serum procalcitonin for burn sepsis in adults[J]. Eur Rev Med Pharmacol Sci, 2023,27(15):7188-7200. DOI: 10.26355/eurrev_202308_33292.
[20]	BarayanD, AbdullahiA, VinaikR, et al. Interleukin-6 blockade, a potential adjunct therapy for post-burn hypermetabolism[J]. FASEB J, 2021,35(5):e21596. DOI: 10.1096/fj.202100388R.
[21]	HagerS, FoldenauerAC, RennekampffHO, et al. Interleukin-6 serum levels correlate with severity of burn injury but not with gender[J]. J Burn Care Res, 2018,39(3):379-386. DOI: 10.1097/BCR.0000000000000604.
[22]	GreenhalghDG, SaffleJR, 4thHolmes JH, et al. American Burn Association consensus conference to define sepsis and infection in burns[J]. J Burn Care Res, 2007,28(6):776-790. DOI: 10.1097/BCR.0b013e3181599bc9.
[23]	ISBI Practice Guidelines Committee, SubcommitteeSteering, SubcommitteeAdvisory. ISBI practice guidelines for burn care[J]. Burns, 2016,42(5):953-1021. DOI: 10.1016/j.burns.2016.05.013.
[24]	GreenhalghDG, HillDM, BurmeisterDM, et al. Surviving Sepsis After Burn Campaign[J]. Burns, 2023,49(7):1487-1524. DOI: 10.1016/j.burns.2023.05.003.
[25]	YinZ, BeiwenW, ZhenzhuM, et al. Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis[J]. Sci Rep, 2022,12(1):20105. DOI: 10.1038/s41598-022-24492-z.